Delivery Order SPE2DB24D2013-SPE2DB25FCJTQ
- Not listed
- The Defense Logistics Agency awarded a $7,264.50 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Menquadfi vial 0.5ml, a meningococcal vaccine product. This firm fixed-price delivery order, with an ultimate completion date of September 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively made with no set-aside designation, and performance will take...
- On July 29, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,452.88 to AmerisourceBergen Drug Corp for the supply of Menquadfi vial 0.5ML, a meningococcal vaccine product. The contract is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation. The delivery order is a...
- The Defense Logistics Agency awarded a $20,340.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Menquadfi vial 0.5ml, a meningococcal vaccine. The award, with an ultimate completion date of September 24, 2025, was competitively awarded with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,990.84 by the Defense Logistics Agency's Medical Supply Chain on August 20, 2025, with an ultimate completion date of August 21, 2025. The contract, designated as a firm fixed-price delivery order without set-aside, covers the supply of Menquadfi vials (0.5mL), a meningococcal vaccine product. This award is issued as a child contract under...
- The Defense Logistics Agency awarded a $1,452.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Menquadfi vial 0.5ml, a meningococcal vaccine product. The contract was competitively awarded with no set-aside designation and is scheduled for completion by August 12, 2025. AmerisourceBergen will perform work from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order valued at $2,179.32 to AmerisourceBergen Drug Corp for the supply of Menquadfi vials (0.5mL) to support federal medical procurement needs. This non-competitive delivery order, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a firm fixed-price transaction under a larger contract vehicle. The work will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $15,255.24 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Menquadfi vial 0.5ML, a meningococcal vaccine product. The delivery order, which represents a child contract action under a larger vehicle, is scheduled for completion by August 19, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $1,452.88 to AmerisourceBergen Drug Corp for the supply of Menquadfi vial 0.5ML on June 2, 2025, with an ultimate completion date of June 3, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and is to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $7,264.50 to AmerisourceBergen Drug Corp for the supply of Menquadfi vials (0.5mL) with a firm fixed price arrangement. The award was made on August 19, 2025, with an ultimate completion date of August 20, 2025, and represents a non-set-aside, competitively awarded procurement. Performance will be executed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for MENQUADFI vials (0.5ML) with a ceiling value of $8,254.21 under a firm fixed-price contract type. The award was made on August 11, 2025, with an ultimate completion date of August 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a competitively awarded, non-set-aside delivery order issued under...
- SPE2DB24D2013Indefinite Delivery Contract
- SPE2DB24D2013-SPE2DB25FCJTQDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of MENQUADFI vial 0.5ML, a meningococcal vaccine product. The contract is valued at $2,179.32 with a firm fixed price structure and an ultimate completion date of July 30, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. Performance will be conducted at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, fulfills this delivery order as part of its comprehensive role in supporting military and federal medical supply chains. The company's extensive portfolio of federal contracts with the Defense Logistics Agency demonstrates its capacity to deliver a wide range of pharmaceutical products and medical supplies across multiple therapeutic domains. This specific delivery order for MENQUADFI vaccine supports the Defense Logistics Agency's mission to ensure adequate pharmaceutical supply for military healthcare programs and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 7/29/25 |